PITINI, Vincenzo
PITINI, Vincenzo
Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST
2014-01-01 Mondello, Patrizia; Altavilla, Giuseppe; Derenzini, E.; Pitini, Vincenzo; Mian, M.
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment.
2014-01-01 Mondello, Patrizia; Pitini, Vincenzo; Arrigo, C.; Derenzini, E.; Mian, M.
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
2016-01-01 Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Arrigo, Carmela; Cuzzocrea, Salvatore; Pitini, Vincenzo; Mian, Michael
A sequential chemoimmunotherapy protocol can obtain a high proportion of molecular remission in chronic lymphocytic leukaemia
2004-01-01 Pitini, Vincenzo; Arrigo, C; Amata, C; LA GATTUTA, G; Siracusano, L; Teti, Diana
Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient
2004-01-01 Pitini, Vincenzo; Bramanti, Placido; Arrigo, C; Sessa, E; LA GATTUTA, G; Amata, C.
ADVERSE PROGNOSTIC FACTOR OF p53 GENE DELECTION DETECTED BY FISH IN MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION
2006-01-01 Arrigo, C; Pitini, Vincenzo; Altavilla, Giuseppe; Naro, C; Righi, M.
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report
2004-01-01 Pitini, Vincenzo; Teti, Diana; Arrigo, Carmela; Righi, Maria
ALTE DOSI: QUESTIONI APERTE E SVILUPPI FUTURI
2000-01-01 Pitini, Vincenzo
Amifostine in conjuction with G-CSF enhances chemoterapy mobilization of peripheral blood progenitor cell
1998-01-01 Pitini, Vincenzo; C., Arrigo; G., Aloi; G., Moruzzi; Garipoli, Claudia; Aragona, Marcello; F., La Torre
AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION
1999-01-01 Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Moruzzi, G.; Picciotto, Maria; Castro, A.; Aragona, Marcello; Latorre, F.
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma
2009-01-01 Altavilla, Giuseppe; Arrigo, Carmela; Sauta, M. G.; Galletti, G.; Gnani, Alessandro; Pettineo, G.; Buemi, B.; Pitini, Vincenzo
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma.
2009-01-01 Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo
An accessory spleen wrongly recognised as relapse by positron emission tomography
2006-01-01 Pitini, Vincenzo; Navarra, Giuseppe; Cavallari, Vittorio; Arrigo, C.
An acute-leukaemia-like picture due to breast carcinoma cells.
2006-01-01 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe
AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS
2003-01-01 Pitini, Vincenzo; Sturniolo, Giuseppe; Cavallari, Vittorio
ANALISI SEQUENZIALE DELLA TRISOMIA 12 NELLA LEUCEMIA LINFATICA CRONICA
1999-01-01 Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Picciotto, Maria; Castro, A.; LA TORRE, F.
ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE
1999-01-01 Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Picciotto, Maria; Aragona, Marcello; LA TORRE, F.
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery
2007-01-01 Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
2015-01-01 Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Vannata, Barbara; Efremov, Dimitar G; Ciolli, Stefania; Del Poeta, Giovanni; Mauro, Francesca Romana; Cortelezzi, Agostino; Borza, Paola Anticoli; Ghio, Francesco; Mondello, Patrizia; Murru, Roberta; Gozzetti, Alessandro; Cariccio, Maria Rosa Lanza; Piccirillo, Nicola; Boncompagni, Riccardo; Cantonetti, Maria; Principe, Maria Ilaria Del; Reda, Gianluigi; Bongarzoni, Velia; Cervetti, Giulia; Pitini, Vincenzo; Foà, Robin; Sica, Simona; D'Arena, Giovanni
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study
2016-01-01 Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Wasle, Ines; Zaja, Francesco; Zambello, Renato; Visentin, Andrea; Mauro, Endri; Ferrero, Simone; Ghione, Paola; Pitini, Vincenzo; Cuzzocrea, Salvatore; Mian, Michael
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST | 1-gen-2014 | Mondello, Patrizia; Altavilla, Giuseppe; Derenzini, E.; Pitini, Vincenzo; Mian, M. | |
| 90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment. | 1-gen-2014 | Mondello, Patrizia; Pitini, Vincenzo; Arrigo, C.; Derenzini, E.; Mian, M. | |
| 90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward? | 1-gen-2016 | Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Arrigo, Carmela; Cuzzocrea, Salvatore; Pitini, Vincenzo; Mian, Michael | |
| A sequential chemoimmunotherapy protocol can obtain a high proportion of molecular remission in chronic lymphocytic leukaemia | 1-gen-2004 | Pitini, Vincenzo; Arrigo, C; Amata, C; LA GATTUTA, G; Siracusano, L; Teti, Diana | |
| Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient | 1-gen-2004 | Pitini, Vincenzo; Bramanti, Placido; Arrigo, C; Sessa, E; LA GATTUTA, G; Amata, C. | |
| ADVERSE PROGNOSTIC FACTOR OF p53 GENE DELECTION DETECTED BY FISH IN MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION | 1-gen-2006 | Arrigo, C; Pitini, Vincenzo; Altavilla, Giuseppe; Naro, C; Righi, M. | |
| Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report | 1-gen-2004 | Pitini, Vincenzo; Teti, Diana; Arrigo, Carmela; Righi, Maria | |
| ALTE DOSI: QUESTIONI APERTE E SVILUPPI FUTURI | 1-gen-2000 | Pitini, Vincenzo | |
| Amifostine in conjuction with G-CSF enhances chemoterapy mobilization of peripheral blood progenitor cell | 1-gen-1998 | Pitini, Vincenzo; C., Arrigo; G., Aloi; G., Moruzzi; Garipoli, Claudia; Aragona, Marcello; F., La Torre | |
| AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION | 1-gen-1999 | Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Moruzzi, G.; Picciotto, Maria; Castro, A.; Aragona, Marcello; Latorre, F. | |
| Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma | 1-gen-2009 | Altavilla, Giuseppe; Arrigo, Carmela; Sauta, M. G.; Galletti, G.; Gnani, Alessandro; Pettineo, G.; Buemi, B.; Pitini, Vincenzo | |
| Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. | 1-gen-2009 | Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo | |
| An accessory spleen wrongly recognised as relapse by positron emission tomography | 1-gen-2006 | Pitini, Vincenzo; Navarra, Giuseppe; Cavallari, Vittorio; Arrigo, C. | |
| An acute-leukaemia-like picture due to breast carcinoma cells. | 1-gen-2006 | Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe | |
| AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS | 1-gen-2003 | Pitini, Vincenzo; Sturniolo, Giuseppe; Cavallari, Vittorio | |
| ANALISI SEQUENZIALE DELLA TRISOMIA 12 NELLA LEUCEMIA LINFATICA CRONICA | 1-gen-1999 | Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Picciotto, Maria; Castro, A.; LA TORRE, F. | |
| ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE | 1-gen-1999 | Pitini, Vincenzo; Arrigo, C.; Aloi, G.; Picciotto, Maria; Aragona, Marcello; LA TORRE, F. | |
| Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery | 1-gen-2007 | Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe | |
| Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments | 1-gen-2015 | Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Vannata, Barbara; Efremov, Dimitar G; Ciolli, Stefania; Del Poeta, Giovanni; Mauro, Francesca Romana; Cortelezzi, Agostino; Borza, Paola Anticoli; Ghio, Francesco; Mondello, Patrizia; Murru, Roberta; Gozzetti, Alessandro; Cariccio, Maria Rosa Lanza; Piccirillo, Nicola; Boncompagni, Riccardo; Cantonetti, Maria; Principe, Maria Ilaria Del; Reda, Gianluigi; Bongarzoni, Velia; Cervetti, Giulia; Pitini, Vincenzo; Foà, Robin; Sica, Simona; D'Arena, Giovanni | |
| Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study | 1-gen-2016 | Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Wasle, Ines; Zaja, Francesco; Zambello, Renato; Visentin, Andrea; Mauro, Endri; Ferrero, Simone; Ghione, Paola; Pitini, Vincenzo; Cuzzocrea, Salvatore; Mian, Michael |